Clinical Trial

Standard Optimization of Stem Cells in Parkinson's Disease and Atypical Parkinsonism

Name: Standard Optimization of Stem Cells in Parkinson's Disease and Atypical Parkinsonism — clinical trial record (NCT06858254)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SO-ASC-INIVAT

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to measure outcomes using intranasal and intravenous autologous bone marrow mesenchymal stem cells (BM-MSCs) for Parkinson Disease (PD) and Parkinson's Plus (PPS) patients.

Trial Details

NCT Number	NCT06858254
Lead Sponsor	Apeiron Research Center Collaborators: University of Colorado, Boulder
Conditions	Atypical Parkinsonism, Parkinson Disease (PD)
Enrollment	60 participants
Start Date	2025-04-01
Primary Completion	2028-04 (estimated)
Study Completion	2028-04 (estimated)
Updated on ClinicalTrials.gov	2025-03-05